Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
11,866,163
-
Shares change
-
-83,292
-
Total reported value, excl. options
-
$76,776,000
-
Value change
-
-$565,886
-
Number of buys
-
5
-
Number of sells
-
-11
-
Price
-
$6.47
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2019
27 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q1 2019.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,866,163 shares
of 71,858,757 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (5,900,000 shares), ORBIMED ADVISORS LLC (2,839,500 shares), RENAISSANCE TECHNOLOGIES LLC (2,375,841 shares), Neumann Advisory Hong Kong Ltd (315,586 shares), STATE STREET CORP (160,875 shares), Yorktown Management & Research Co Inc (74,893 shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (68,732 shares), GEODE CAPITAL MANAGEMENT, LLC (27,717 shares), RAMSEY QUANTITATIVE SYSTEMS (23,129 shares), and NORTHERN TRUST CORP (22,374 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.